Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial by Dmitriy Zamarin, Taha Merghoub, Yanyun Li, Travis J Hollmann, Jason A Konner, Qin Zhou, Carol Aghajanian, Roisin E O’Cearbhaill, Aliya Holland, Rachel N Grisham, Keith L Knutson, Sven Walderich, Alexia E Iasonos, Jean M Torrisi, Lewis F Chesebrough, Autumn S Mcdonnell, Jacqueline M Gallagher, Courtney L Erskine

Get full text